The Executive Member for Adult Social Care,
Public Health, Public Protection and Digital Inclusion and the Director of
Public Health submitted a report for consideration.
The report sought approval to extend the specialist
clinical/prescribing contract for substance misuse by one year, to 31/3/24.
This would allow safe and sufficient
timescales to carry out system consultation in planning the new model, a
procurement exercise and a seamless transition to future steps:
full appraisal and appropriate management of risks;
necessary clinical safety and quality to be maintained.
It also enabled planning and actions to be
carried out in tandem with Integrated Care Board (ICB) colleagues, which was essential
given the co-dependencies of the current service between health and public
decisions were considered but were not recommended for the following reasons:
out the procurement and implementation of a new service by 1/4/23 – unfeasible
due to the unsafe timescales (as detailed earlier in this report);
a suitable provider who could provide a temporary service, in place by 1/4/23
in order to enable realistic timeframe to carry out a procurement exercise –
this option presented too much risk regarding staffing (losing the clinical
team was likely as they would prefer to stay within NHS settings), prescribing
systems (a new case management system with prescribing functionality would have
been required, as well as the data transfer of all current patients and their
medications) and delivery locations (a new building would be required), plus
the amount of work involved to mobilise this and then potentially have to do
the full transition again within a short period of time;
award of a contract and/or work in partnership with another statutory
organisation to design and implement an appropriate new service by 1/4/23 – the
risk of challenge from other providers was deemed to be too great by corporate
legal and procurement teams;
nothing – not a feasible option as the outcome would be having no service
provision on 1/4/23.
That a one year contract extension, covering
the period 1/4/23 – 31/3/24, subject to agreement of all the financial or exempt
information contained in Part B of the report be approved.
There was no option
to risk having any break in service provision. This would have resulted in
serious risk of overdoses and deaths, and would have had extremely negative
consequences for a large number of extremely vulnerable people. This decision
provided appropriate timescales to enable the future service to be planned,
developed and implemented safely, in conjunction with relevant partners and
The whole review process
and associated uncertainty had caused a significant impact on the service and
their ability to retain key staff. Due to Foundations having served notice on
all of their contracts, they had already informed their staff that the service
was going to cease.
If there was a delay
of another month, the risk of losing a significant number of staff was
amplified, particularly in terms of the clinical roles. These were very
difficult to recruit in normal circumstances but, if there was only just over a
year of a contract left for Foundations, they would be virtually impossible to
replace. By their nature, these roles tended to be most critical to the running
of the service and, given the uncertainties around the future, staff were
already unsettled. Further losses would have left the Council in a position
where we the provider was unable to deliver the service.
was available to provide the extension without causing financial pressure on
It enabled public
health to work with the ICB and wider stakeholders within the local system, in
terms designing the best solution to meet local needs and across the scope of
all service elements. This work was already underway and would continue as a
priority to ensure that the new service delivery, regardless of the provider,
would be in place for 1/4/24.